COM:LARIMARTX
Larimar Therapeutics
- Stock
Last Close
9.04
13/11 21:00
Market Cap
584.11M
Beta: -
Volume Today
943.29K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 1.58M - | 1.57M 1.01% | -120K 107.66% | -104K 13.33% | |||||||
average payables | 4.92M - | 5.03M 2.28% | 2.80M 44.45% | 3.31M 18.20% | 3.56M 7.85% | 3.09M 13.41% | 2.15M 30.44% | 1.67M 22.08% | 1.48M 11.27% | ||
average receivables | 661.50K - | 835K 26.23% | 646.50K 22.57% | 1.24M 91.96% | 847K 31.75% | 95K 88.78% | 120K 26.32% | 104K 13.33% | |||
book value per share | 0.01 - | 75.85 885,115.09% | 53.51 29.45% | 34.22 36.06% | 34.73 1.50% | -0.08 100.22% | 7.55 10,120.68% | 3.75 50.28% | 4.31 14.72% | 1.86 56.76% | |
capex per share | -0.00 - | -0.27 5,608,306.86% | -0.29 8.72% | -0.02 91.71% | -0.04 67.15% | -0.01 77.60% | -0.01 42.08% | -0.02 271.84% | -0.00 79.99% | -0.00 3.76% | |
capex to depreciation | -3.63 - | -8.50 134.48% | -3.11 63.37% | -0.29 90.60% | -0.41 41.44% | -1.06 157.16% | -0.40 62.41% | -1.02 155.37% | -0.31 69.21% | -0.53 67.69% | |
capex to operating cash flow | 0.00 - | 0.01 386.47% | 0.01 27.10% | 0.00 90.11% | 0.00 66.99% | 0.00 74.32% | 0.00 59.82% | 0.01 438.30% | 0.00 54.14% | 0.00 35.13% | |
capex to revenue | |||||||||||
cash per share | 0.01 - | 83.01 876,231.87% | 56.80 31.58% | 44.64 21.40% | 43.96 1.52% | 4.78 89.12% | 7.80 63.03% | 4.08 47.61% | 4.60 12.57% | 1.98 57.00% | |
days of inventory on hand | |||||||||||
days payables outstanding | 1.51K - | ||||||||||
days sales outstanding | |||||||||||
debt to assets | 0.06 - | 0.03 47.47% | 0.00 90.87% | 0.19 6,045.19% | 0.17 10.57% | 2.89 1,603.33% | 0.06 97.84% | 0.08 22.56% | 0.04 43.93% | 0.06 35.12% | |
debt to equity | 0.07 - | 0.04 47.79% | 0.00 91.17% | 0.26 7,566.37% | 0.22 13.46% | -21.64 9,878.24% | 0.07 100.34% | 0.09 28.24% | 0.05 47.67% | 0.07 39.17% | |
dividend yield | |||||||||||
earnings yield | -0.00 - | -5.30 5,444,879.85% | -8.00 51.05% | -4.93 38.43% | -4.62 6.29% | -2.26 51.00% | -0.17 92.64% | -0.27 63.28% | -0.32 18.28% | -0.18 42.43% | |
enterprise value | 375.86B - | -15.18M 100.00% | -21.53M 41.81% | -10.22M 52.55% | -15.40M 50.72% | 9.32M 160.50% | 192.79M 1,969.59% | 121.11M 37.18% | 84.98M 29.83% | 178.55M 110.11% | |
enterprise value over ebitda | -10.58K - | 0.20 100.00% | 0.38 84.78% | 0.20 46.53% | 0.25 24.97% | -0.40 260.44% | -4.50 1,018.64% | -2.40 46.72% | -2.33 3.06% | -4.31 85.17% | |
ev to operating cash flow | -13.31K - | 0.25 100.00% | 0.41 62.49% | 0.23 43.67% | 0.30 28.17% | -0.41 237.23% | -4.57 1,013.24% | -2.88 37.04% | -3.08 7.16% | -5.34 73.12% | |
ev to sales | |||||||||||
free cash flow per share | -0.00 - | -26.98 1,161,904.64% | -23.14 14.23% | -19.18 17.12% | -19.21 0.18% | -2.47 87.13% | -3.56 43.83% | -2.47 30.48% | -1.07 56.56% | -0.77 28.69% | |
free cash flow yield | -0.00 - | -4.29 5,697,232.76% | -7.28 69.65% | -4.15 42.95% | -3.88 6.50% | -2.23 42.60% | -0.17 92.54% | -0.23 37.95% | -0.26 13.49% | -0.17 35.27% | |
graham net net | 0.01 - | 74.49 886,695.26% | 52.56 29.44% | 33.01 37.19% | 33.78 2.33% | 4.33 87.19% | 6.53 51.03% | 3.26 50.17% | 4.00 22.69% | 1.65 58.62% | |
graham number | 0.02 - | 238.45 991,395.35% | 175.03 26.60% | 132.37 24.37% | 133.63 0.95% | 2.06 98.46% | 24.59 1,092.35% | 15.73 36.04% | 11.34 27.93% | 5.94 47.63% | |
income quality | 0.77 - | 0.80 3.55% | 0.90 12.02% | 0.84 6.29% | 0.84 0.30% | 0.98 16.96% | 0.99 1.23% | 0.83 16.29% | 0.78 6.22% | 0.91 16.13% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | 40.84 - | 156.05 282.09% | -167.80 207.52% | -54.58 67.47% | 248.46 555.21% | 13.14 94.71% | 114.86 - | ||||
interest debt per share | 0.00 - | 2.65 483,495.71% | 0.33 87.52% | 9.17 2,671.26% | 7.59 17.22% | 1.44 81.06% | 0.55 61.87% | 0.35 36.24% | 0.20 43.50% | 0.13 36.06% | |
inventory turnover | |||||||||||
invested capital | 0.07 - | 0.04 47.79% | 0.00 91.17% | 0.26 7,566.37% | 0.22 13.46% | -21.64 9,878.24% | 0.07 100.34% | 0.09 28.24% | 0.05 47.67% | 0.07 39.17% | |
market cap | 375.91B - | 14.02M 100.00% | 7.23M 48.42% | 10.56M 46.00% | 13.29M 25.87% | 10.23M 23.07% | 254.42M 2,387.66% | 185.20M 27.21% | 106.39M 42.55% | 199.75M 87.75% | |
net current asset value | 104.12M - | 168.11M 61.46% | 121.00M 28.02% | 77.63M 35.84% | 92.84M 19.59% | -1.15M 101.23% | 82.96M 7,345.24% | 57.95M 30.15% | 105.24M 81.60% | 75.96M 27.82% | |
net debt to ebitda | 1.42 - | 0.39 72.51% | 0.50 28.33% | 0.41 18.61% | 0.47 14.49% | 0.04 91.57% | 1.44 3,552.65% | 1.27 11.79% | 0.59 53.83% | 0.51 12.75% | |
net income per share | -0.00 - | -33.32 1,110,435.77% | -25.44 23.63% | -22.76 10.55% | -22.85 0.40% | -2.51 89.01% | -3.56 41.88% | -2.93 17.71% | -1.33 54.73% | -0.84 36.57% | |
operating cash flow per share | -0.00 - | -26.71 1,152,772.83% | -22.85 14.46% | -19.15 16.17% | -19.17 0.10% | -2.46 87.15% | -3.55 44.14% | -2.45 30.92% | -1.07 56.37% | -0.76 28.78% | |
payables turnover | 0.24 - | ||||||||||
receivables turnover | |||||||||||
research and ddevelopement to revenue | |||||||||||
return on tangible assets | -0.31 - | -0.39 26.24% | -0.44 11.94% | -0.49 12.14% | -0.50 2.21% | -4.45 782.46% | -0.40 90.91% | -0.64 58.17% | -0.27 57.71% | -0.39 42.42% | |
revenue per share | |||||||||||
roe | -0.35 - | -0.44 25.45% | -0.48 8.24% | -0.67 39.90% | -0.66 1.09% | 33.33 5,165.92% | -0.47 101.42% | -0.78 65.51% | -0.31 60.54% | -0.45 46.69% | |
roic | -0.32 - | -0.42 30.88% | -0.48 16.19% | -0.56 16.02% | -0.53 4.91% | -1.61 202.45% | -0.42 74.21% | -0.66 58.04% | -0.29 55.78% | -0.45 56.48% | |
sales general and administrative to revenue | |||||||||||
shareholders equity per share | 0.01 - | 75.85 885,115.09% | 53.51 29.45% | 34.22 36.06% | 34.73 1.50% | -0.08 100.22% | 7.55 10,120.68% | 3.75 50.28% | 4.31 14.72% | 1.86 56.76% | |
stock based compensation to revenue | |||||||||||
tangible asset value | 104.44M - | 169.11M 61.92% | 121.73M 28.02% | 78.22M 35.74% | 93.27M 19.25% | -694K 100.74% | 89.69M 13,023.92% | 64.41M 28.18% | 110.90M 72.17% | 81.72M 26.31% | |
tangible book value per share | 0.01 - | 75.85 885,115.09% | 53.51 29.45% | 34.22 36.06% | 34.73 1.50% | -0.08 100.22% | 7.55 10,120.68% | 3.75 50.28% | 4.31 14.72% | 1.86 56.76% | |
working capital | 110.30M - | 171.57M 55.55% | 121.00M 29.47% | 97.63M 19.32% | 108.02M 10.64% | -1.15M 101.06% | 88.96M 7,869.43% | 63.36M 28.78% | 110.03M 73.67% | 80.67M 26.69% |
All numbers in (except ratios and percentages)